These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30844538)

  • 61. Dengue Virus and Zika Virus Serological Cross-reactivity and Their Impact on Pathogenesis in Mice.
    Watanabe S; Tan NWW; Chan KWK; Vasudevan SG
    J Infect Dis; 2019 Jan; 219(2):223-233. PubMed ID: 30085051
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Antigenic evolution of dengue viruses over 20 years.
    Katzelnick LC; Coello Escoto A; Huang AT; Garcia-Carreras B; Chowdhury N; Maljkovic Berry I; Chavez C; Buchy P; Duong V; Dussart P; Gromowski G; Macareo L; Thaisomboonsuk B; Fernandez S; Smith DJ; Jarman R; Whitehead SS; Salje H; Cummings DAT
    Science; 2021 Nov; 374(6570):999-1004. PubMed ID: 34793238
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Near-atomic resolution cryo-electron microscopic structure of dengue serotype 4 virus.
    Kostyuchenko VA; Chew PL; Ng TS; Lok SM
    J Virol; 2014 Jan; 88(1):477-82. PubMed ID: 24155405
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Generation and characterization of mouse monoclonal antibodies against NS4B protein of dengue virus.
    Xie X; Zou J; Wang QY; Noble CG; Lescar J; Shi PY
    Virology; 2014 Feb; 450-451():250-7. PubMed ID: 24503088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Current Understanding of the Pathogenesis of Dengue Virus Infection.
    Bhatt P; Sabeena SP; Varma M; Arunkumar G
    Curr Microbiol; 2021 Jan; 78(1):17-32. PubMed ID: 33231723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serotype-specific and cross-reactive neutralizing antibody responses in cynomolgus monkeys after infection with multiple dengue virus serotypes.
    Ito M; Katakai Y; Ono F; Akari H; Mukai RZ; Takasaki T; Kotaki A; Kurane I
    Arch Virol; 2011 Jun; 156(6):1073-7. PubMed ID: 21409446
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of Dengue Virus Serotype-Specific NS1 Capture Assays for the Rapid and Highly Sensitive Identification of the Infecting Serotype in Human Sera.
    Röltgen K; Rose N; Ruggieri A; Warryn L; Scherr N; Pinho-Nascimento CA; Tamborrini M; Jaenisch T; Pluschke G
    J Immunol; 2018 Jun; 200(11):3857-3866. PubMed ID: 29661824
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A lethal model of disseminated dengue virus type 1 infection in AG129 mice.
    Milligan GN; Sarathy VV; White MM; Greenberg MB; Campbell GA; Pyles RB; Barrett ADT; Bourne N
    J Gen Virol; 2017 Oct; 98(10):2507-2519. PubMed ID: 28949904
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Sweeping analysis of transcript profile in dengue virus serotype 3 infection and antibody-dependent enhancement of infection.
    Long M; Pan Y; Chen J; Jia F; Wang H; Li D; Feng K; Yan L; Wang X; Ning X; Qiu L; Zhang J; Sun Q
    Virulence; 2021 Dec; 12(1):2764-2776. PubMed ID: 34699307
    [TBL] [Abstract][Full Text] [Related]  

  • 70. How antibodies alter the cell entry pathway of dengue virus particles in macrophages.
    Ayala-Nunez NV; Hoornweg TE; van de Pol DP; Sjollema KA; Flipse J; van der Schaar HM; Smit JM
    Sci Rep; 2016 Jul; 6():28768. PubMed ID: 27385443
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human monoclonal single-chain antibodies specific to dengue virus envelope protein.
    Saokaew N; Poungpair O; Panya A; Tarasuk M; Sawasdee N; Limjindaporn T; Chaicumpa W; Yenchitsomanus P
    Lett Appl Microbiol; 2014 Mar; 58(3):270-7. PubMed ID: 24266517
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Delayed antibody dependent enhancement of low passage dengue virus 4 isolates.
    Wikan N; Libsittikul S; Yoksan S; Auewarakul P; Smith DR
    BMC Res Notes; 2015 Sep; 8():399. PubMed ID: 26328895
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibodies against immature virions are not a discriminating factor for dengue disease severity.
    Rodenhuis-Zybert IA; da Silva Voorham JM; Torres S; van de Pol D; Smit JM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003564. PubMed ID: 25760350
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intrinsic ADE: The Dark Side of Antibody Dependent Enhancement During Dengue Infection.
    Narayan R; Tripathi S
    Front Cell Infect Microbiol; 2020; 10():580096. PubMed ID: 33123500
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Protection against dengue virus requires a sustained balance of antibody and T cell responses.
    Valentine KM; Croft M; Shresta S
    Curr Opin Virol; 2020 Aug; 43():22-27. PubMed ID: 32798886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IFITM proteins restrict antibody-dependent enhancement of dengue virus infection.
    Chan YK; Huang IC; Farzan M
    PLoS One; 2012; 7(3):e34508. PubMed ID: 22479637
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sulfated polysaccharide, curdlan sulfate, efficiently prevents entry/fusion and restricts antibody-dependent enhancement of dengue virus infection in vitro: a possible candidate for clinical application.
    Ichiyama K; Gopala Reddy SB; Zhang LF; Chin WX; Muschin T; Heinig L; Suzuki Y; Nanjundappa H; Yoshinaka Y; Ryo A; Nomura N; Ooi EE; Vasudevan SG; Yoshida T; Yamamoto N
    PLoS Negl Trop Dis; 2013; 7(4):e2188. PubMed ID: 23658845
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibody-Dependent Enhancement of Severe Disease Is Mediated by Serum Viral Load in Pediatric Dengue Virus Infections.
    Waggoner JJ; Katzelnick LC; Burger-Calderon R; Gallini J; Moore RH; Kuan G; Balmaseda A; Pinsky BA; Harris E
    J Infect Dis; 2020 May; 221(11):1846-1854. PubMed ID: 32236481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro.
    Nicholson CO; Costin JM; Rowe DK; Lin L; Jenwitheesuk E; Samudrala R; Isern S; Michael SF
    Antiviral Res; 2011 Jan; 89(1):71-4. PubMed ID: 21093488
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Impact of tetravalent dengue vaccination with screening, ADE, and altered infectivity on single-serotype dengue and Zika transmission.
    Kribs C; Greenhalgh D
    J Math Biol; 2023 Apr; 86(5):85. PubMed ID: 37119296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.